Results 121 to 130 of about 17,623 (223)

PCOS and Inositols – Advances and Lessons We are Learning. A Narrative Review

Drug Design, Development and Therapy
Guglielmo Lentini, Alessandro Querqui, Noemi Monti, Mariano Bizzarri Department of Experimental Medicine, Space Biomedicine Laboratory, University Sapienza, Rome, ItalyCorrespondence: Mariano Bizzarri, Email mariano.bizzarri@uniroma1.itIntroduction: This
Lentini G, Querqui A, Monti N, Bizzarri M   +3 more
doaj  

Commentary: Clinical utility of anthropometric parameters in identifying glucose dysregulation in women with polycystic ovary syndrome. [PDF]

Front Endocrinol (Lausanne)
Liu J, Hu Z, Pan J.
europepmc   +1 more source

A New Diagnostic Strategy for Polycystic Ovary Syndrome Combining Japanese and International Diagnostic Criteria Using Anti-Müllerian Hormone. [PDF]

J Obstet Gynaecol Res
Noguchi H, Iwasa T, Iwase A, Kanasaki H, Kimura F, Kugu K, Saito K, Baba T, Hara T, Matsuzaki T.   +9 more
europepmc   +1 more source

A Case Report: Treatment, follow-up, and literature review of type A insulin resistance syndrome caused by a <i>De Novo</i> INSR c.3328G>C mutation. [PDF]

Front Endocrinol (Lausanne)
Ji C, Zheng X, Wang Q, Chen Z.
europepmc   +1 more source

Downregulation of DACH2 Expression in an Adrenocortical Cell Model of PCOS with Adrenal Hyperandrogenism, and in Human Granulosa Cells from Patients with Hyperandrogenic-PCOS: a Link Between Ovaries and Adrenal Glands in PCOS. [PDF]

Reprod Sci
Berkel C.
europepmc   +1 more source

Severe Hyperandrogenism Revealing a 46,XY Disorder of Sex Development Due to a Novel NR5A1 Mutation. [PDF]

Cureus
Yakine F, Bouarab I, Alaoui-Inboui FZ, Idrissifawzi F, Slaoui B.   +4 more
europepmc   +1 more source

Polycystic ovarian syndrome-associated hyperandrogenism and metabolic dysfunction. [PDF]

Proc (Bayl Univ Med Cent)
Bates GW.
europepmc   +1 more source

Bilateral ovarian steroid cell tumor in a postmenopausal woman with progressive hyperandrogenism. [PDF]

JCEM Case Rep
Tapia Sanchiz MS, Justel Enríquez A, Álvarez RM, Sebastian-Valles F, Marazuela M.   +4 more
europepmc   +1 more source

Natural Bioactive Compounds in Polycystic Ovary Syndrome: Properties, Molecular Mechanisms, and Therapeutic Potential. [PDF]

Int J Mol Sci
Linares R, Rosas G, Vieyra E, Chaparro A, Espinoza JA, Ramírez DLA, Silva CC, Rosas P, Macías VM, Morales-Ledesma L.   +9 more
europepmc   +1 more source

Androgenetic alopecia in polycystic ovary syndrome: a cutaneous marker of systemic metabo-inflammatory and endocrine dysfunction. [PDF]

Endocr Connect
Motafeghi F, Saei Ghare Naz M, Ramezani Tehrani F, Behboudi-Gandevani S.   +3 more
europepmc   +1 more source